Silco Pharmaceuticals Limited (DSE:SILCOPHL)

Market Cap	1.43B
Revenue (ttm)	428.63M
Net Income (ttm)	46.56M
Shares Out	103.81M
EPS (ttm)	0.45
PE Ratio	30.57
Forward PE	n/a
Dividend	0.10 (0.70%)
Ex-Dividend Date	Dec 9, 2024

Volume	233,125
Average Volume	313,230
Open	13.90
Previous Close	13.90
Day's Range	13.90 - 14.30
52-Week Range	12.60 - 18.50
Beta	0.21
RSI	39.78
Earnings Date	Nov 25, 2025

About Silco Pharmaceuticals

Silco Pharmaceuticals Limited engages in manufacturing and marketing of finished pharmaceutical products in Bangladesh and internationally. It offers products in the therapeutic areas of analgesic and antipyretic, anti-platelet, antiasthmatic, antibiotic, antidepressant, antidiabetic, antiemetic, antifungal, antihistamin, antihypertensive and antianginal, antimicrobial, antiprotozoal, antispasmodic, antiulcerant, anxiolytic, calcium and combinations, central muscle relaxants, diuretics, gastroprokinetic, haematinic, vitamins and minerals, laxat...

• Industry: Pharmaceutical Preparations
• Founded: 1995
• Employees: 313
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: SILCOPHL

Financial Performance

In 2024, Silco Pharmaceuticals's revenue was 410.10 million, a decrease of -11.75% compared to the previous year's 464.70 million. Earnings were 45.88 million, a decrease of -33.72%.